True about Ca vulva associated/predisposed by:
**Question:** True about Ca vulva associated/predisposed by:
A. Hormonal imbalance
B. Infection
C. Trauma
D. Genetic predisposition
**Core Concept:**
Ca vulva, also known as condyloma acuminata, is a sexually transmitted infection (STI) caused by human papillomavirus (HPV) infection. HPV infection affects the squamous epithelial cells of the genitalia, leading to the formation of flat, wart-like lesions that can grow into the underlying tissues. The clinical presentation is characterized by the presence of condylomata (warts) on the vulva, vagina, or anus, which are associated with sexual activity, especially unprotected intercourse in women.
**Why the Correct Answer is Right:**
D. Genetic predisposition plays a role in Ca vulva development, as some HPV strains have been associated with a higher risk of progression to invasive cervical cancer in women with a history of HPV infection and persistent infection. Additionally, the presence of multiple HPV types and the host immune response may impact the clinical presentation and severity of Ca vulva.
**Why Each Wrong Option is Incorrect:**
A. Hormonal imbalance is not a direct cause of Ca vulva, but it can exacerbate the symptoms and potentially lead to more frequent genital warts in women with hormonal imbalances (e.g., during pregnancy, contraceptive pill use).
B. Infection is a primary cause of Ca vulva, as it is a sexually transmitted infection. However, it is not the primary predisposing factor.
C. Trauma is not a predisposing factor for Ca vulva, as the infection is acquired through sexual contact and not caused by external injuries.
**Clinical Pearl:**
Understanding the predisposing factors of Ca vulva is essential for healthcare providers to counsel patients on preventive measures, such as practicing safe sex and getting vaccinated against HPV. The HPV vaccine is available for both males and females and can prevent multiple HPV types, including those associated with Ca vulva. In addition, women should be screened for Ca vulva and cervical cancer through Pap smears or liquid-based cytology tests during routine gynecological exams.